AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (664.4 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Precision individualized medication strategies and challenges for cardiovascular diseases

Ting Yina,b,c( )Jingsi Duana,b,cDong XudMengying HuangaDeling Yina,b,c( )
Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
State Key Laboratory of Transvascular Implantation Devices, Hangzhou 310009, China
Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou 310009, China
Department of Vascular Surgery, the Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310000, China
Show Author Information

Abstract

With the ongoing societal development and changes in lifestyle, the incidence of cardiovascular diseases continues to rise. Although the most effective means of preventing atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation is the lifelong promotion of a healthy lifestyle, pharmacological treatment plays a critical role in the comprehensive management of cardiovascular diseases, with an increasing demand for effective drug management. Effective medication management aids in controlling disease progression, reducing the occurrence of complications, and improving patients' quality of life. Therefore, understanding and mastering the importance of drug toxicity and prescription review in the management of cardiovascular diseases is crucial. Moreover, outpatient time plays a pivotal role in the treatment and recovery of patients. Through appropriate medication management and outpatient practices, better patient management and personalized medical services can be achieved. This paper will focus on discussing the significance of drug toxicity and prescription review in the context of cardiovascular disease management.

References

【1】
【1】
 
 
Precision Medication

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Yin T, Duan J, Xu D, et al. Precision individualized medication strategies and challenges for cardiovascular diseases. Precision Medication, 2024, 1(1). https://doi.org/10.1016/j.prmedi.2024.10.005

676

Views

68

Downloads

2

Crossref

Received: 25 July 2024
Accepted: 23 August 2024
Published: 31 October 2024
© 2024 Chinese General Practice Publishing House Co., Ltd.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).